Global Transcriptomics Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI01244668

Publication Date:

January 4, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Transcriptomics market size was valued at US$ 3693.1 million in 2023. With growing demand in downstream market, the Transcriptomics is forecast to a readjusted size of US$ 7369.7 million by 2030 with a CAGR of 10.4% during review period.
The research report highlights the growth potential of the global Transcriptomics market. Transcriptomics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Transcriptomics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Transcriptomics market.
Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
North America is the largest consumption place, with a consumption market share nearly 55% . Following North America, Europe is the second largest consumption place with the consumption market share of 25% .The key manufacturers are Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm etc. Top 3 companies occupied about 41% market share.
Key Features:
The report on Transcriptomics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Transcriptomics market. It may include historical data, market segmentation by Type (e.g., PCR, Microarray), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Transcriptomics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Transcriptomics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Transcriptomics industry. This include advancements in Transcriptomics technology, Transcriptomics new entrants, Transcriptomics new investment, and other innovations that are shaping the future of Transcriptomics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Transcriptomics market. It includes factors influencing customer ' purchasing decisions, preferences for Transcriptomics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Transcriptomics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Transcriptomics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Transcriptomics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Transcriptomics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Transcriptomics market.
Market Segmentation:
Transcriptomics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
PCR
Microarray
Sequencing
Segmentation by application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transcriptomics Market Size 2019-2030
2.1.2 Transcriptomics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Transcriptomics Segment by Type
2.2.1 PCR
2.2.2 Microarray
2.2.3 Sequencing
2.3 Transcriptomics Market Size by Type
2.3.1 Transcriptomics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Transcriptomics Market Size Market Share by Type (2019-2024)
2.4 Transcriptomics Segment by Application
2.4.1 Pharmaceutical and Biotechnology
2.4.2 Academic Research and Government Institutes
2.4.3 Hospitals and Diagnostic Centers
2.5 Transcriptomics Market Size by Application
2.5.1 Transcriptomics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Transcriptomics Market Size Market Share by Application (2019-2024)
3 Transcriptomics Market Size by Player
3.1 Transcriptomics Market Size Market Share by Players
3.1.1 Global Transcriptomics Revenue by Players (2019-2024)
3.1.2 Global Transcriptomics Revenue Market Share by Players (2019-2024)
3.2 Global Transcriptomics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Transcriptomics by Regions
4.1 Transcriptomics Market Size by Regions (2019-2024)
4.2 Americas Transcriptomics Market Size Growth (2019-2024)
4.3 APAC Transcriptomics Market Size Growth (2019-2024)
4.4 Europe Transcriptomics Market Size Growth (2019-2024)
4.5 Middle East & Africa Transcriptomics Market Size Growth (2019-2024)
5 Americas
5.1 Americas Transcriptomics Market Size by Country (2019-2024)
5.2 Americas Transcriptomics Market Size by Type (2019-2024)
5.3 Americas Transcriptomics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transcriptomics Market Size by Region (2019-2024)
6.2 APAC Transcriptomics Market Size by Type (2019-2024)
6.3 APAC Transcriptomics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Transcriptomics by Country (2019-2024)
7.2 Europe Transcriptomics Market Size by Type (2019-2024)
7.3 Europe Transcriptomics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Transcriptomics by Region (2019-2024)
8.2 Middle East & Africa Transcriptomics Market Size by Type (2019-2024)
8.3 Middle East & Africa Transcriptomics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Transcriptomics Market Forecast
10.1 Global Transcriptomics Forecast by Regions (2025-2030)
10.1.1 Global Transcriptomics Forecast by Regions (2025-2030)
10.1.2 Americas Transcriptomics Forecast
10.1.3 APAC Transcriptomics Forecast
10.1.4 Europe Transcriptomics Forecast
10.1.5 Middle East & Africa Transcriptomics Forecast
10.2 Americas Transcriptomics Forecast by Country (2025-2030)
10.2.1 United States Transcriptomics Market Forecast
10.2.2 Canada Transcriptomics Market Forecast
10.2.3 Mexico Transcriptomics Market Forecast
10.2.4 Brazil Transcriptomics Market Forecast
10.3 APAC Transcriptomics Forecast by Region (2025-2030)
10.3.1 China Transcriptomics Market Forecast
10.3.2 Japan Transcriptomics Market Forecast
10.3.3 Korea Transcriptomics Market Forecast
10.3.4 Southeast Asia Transcriptomics Market Forecast
10.3.5 India Transcriptomics Market Forecast
10.3.6 Australia Transcriptomics Market Forecast
10.4 Europe Transcriptomics Forecast by Country (2025-2030)
10.4.1 Germany Transcriptomics Market Forecast
10.4.2 France Transcriptomics Market Forecast
10.4.3 UK Transcriptomics Market Forecast
10.4.4 Italy Transcriptomics Market Forecast
10.4.5 Russia Transcriptomics Market Forecast
10.5 Middle East & Africa Transcriptomics Forecast by Region (2025-2030)
10.5.1 Egypt Transcriptomics Market Forecast
10.5.2 South Africa Transcriptomics Market Forecast
10.5.3 Israel Transcriptomics Market Forecast
10.5.4 Turkey Transcriptomics Market Forecast
10.5.5 GCC Countries Transcriptomics Market Forecast
10.6 Global Transcriptomics Forecast by Type (2025-2030)
10.7 Global Transcriptomics Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Transcriptomics Product Offered
11.1.3 Thermo Fisher Scientific Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Illumina
11.2.1 Illumina Company Information
11.2.2 Illumina Transcriptomics Product Offered
11.2.3 Illumina Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Illumina Main Business Overview
11.2.5 Illumina Latest Developments
11.3 QIAGEN (Exiqon)
11.3.1 QIAGEN (Exiqon) Company Information
11.3.2 QIAGEN (Exiqon) Transcriptomics Product Offered
11.3.3 QIAGEN (Exiqon) Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 QIAGEN (Exiqon) Main Business Overview
11.3.5 QIAGEN (Exiqon) Latest Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Information
11.4.2 Agilent Technologies Transcriptomics Product Offered
11.4.3 Agilent Technologies Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Agilent Technologies Main Business Overview
11.4.5 Agilent Technologies Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Transcriptomics Product Offered
11.5.3 Roche Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 GE Healthcare
11.6.1 GE Healthcare Company Information
11.6.2 GE Healthcare Transcriptomics Product Offered
11.6.3 GE Healthcare Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 GE Healthcare Main Business Overview
11.6.5 GE Healthcare Latest Developments
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Information
11.7.2 Bio-Rad Laboratories Transcriptomics Product Offered
11.7.3 Bio-Rad Laboratories Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Bio-Rad Laboratories Main Business Overview
11.7.5 Bio-Rad Laboratories Latest Developments
11.8 Fluidigm
11.8.1 Fluidigm Company Information
11.8.2 Fluidigm Transcriptomics Product Offered
11.8.3 Fluidigm Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Fluidigm Main Business Overview
11.8.5 Fluidigm Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂